SciELO - Scientific Electronic Library Online

 
vol.24 número6Conocimiento de la enfermedad vascular cerebral en la Ciudad de MéxicoAtención agrupada para optimizar los resultados tras una hemorragia intracerebral: medidas para una aplicación eficaz índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista mexicana de neurociencia

versión On-line ISSN 2604-6180versión impresa ISSN 1665-5044

Rev. mex. neurocienc. vol.24 no.6 Ciudad de México nov./dic. 2023  Epub 16-Abr-2024

https://doi.org/10.24875/rmn.23000052 

ORIGINAL ARTICLES

Intracranial hemorrhage outcomes in the Latin American Stroke Registry

Resultados de la hemorragia intracraneal en el Registro Latinoamericano de Enfermedad Vascular Cerebral

Fabiola Serrano1 

Miguel A. Barboza1 

Sebastian F. Ameriso1 

Virginia Pujol-Lereis1 

Alan Flores1 

Hernan Bayona1 

Huberth Fernández1 

Alejandro Castillo1 

Rosa Ecos1 

Jorge Vazquez1 

Pablo Amaya1 

Angélica Ruiz1 

Minerva López1 

Carlos Zapata1 

Luis Roa1 

Juan M. Marquez-Romero1 

Marco A. Ochoa1 

Eugenia Morelos1 

Carolina León1 

Felipe Romero1 

Jose L. Ruiz-Sandoval1 

Abraham Reyes1 

Antonio Arauz1  * 

1Latin American Stroke Registry, Mexico City, Mexico


Abstract

Background:

Intracranial hemorrhage (ICH) carries a significant morbidity and mortality burden; however, there is scarce information in Latin American.

Objective:

To analyze the functional prognosis and mortality rates among participants in the Latin American Stroke Registry (LASE).

Methods:

Eighteen centers across Latin American compiled data on demographics, vascular risk factors, clinical stroke description, ancillary tests, and functional outcomes in hospital stay of patients included from January 2012 to January 2017. All these variables were analyzed based on functional outcome at hospital discharge.

Results:

We included 495 patients with ICH, representing 10.3% of all collected stroke subtypes in LASE. The median in-hospital stay was 9 days (interquartile range, 1-30); 285 (57.6%) were male (median age, 62 years) and 210 female (median age, 65 years). A poor functional outcome (modified Rankin scale, 3-6) was observed in 214 (43.2%) patients, with 62.5% of women (p < 0.009). Mortality was documented in 12.5% of ICH patients. The Kaplan-Meier survival curves presented difference in mortality, with higher frequency in patients > 80 years (HR 1.89, 95%CI 1.07-3.35, p = 0.028), with GCS < 8 (HR 0.19, 95%CI 0.11-0.33, p = < 0.001), ventricular irruption (HR 1.88, 95%CI 1.09-3.24, p = 0.0282), and hematoma volume > 30 cc (HR 2.36, 95%CI 1.17 - 4.77, p = 0.016).

Conclusions:

Our study demonstrates a poor functional prognosis in 43.2% of ICH patients, with the risk factors for higher mortality being age over 80 years, higher GCS values, and ventricular irruption in the LASE. Our collaborative study contributes substantial insight into the factors influencing ICH occurrence, prognosis, and outcomes in Latin America.

Keywords Intracranial hemorrhage; Latin America; Stroke registry; Stroke outcome

Resumen

Introducción:

La Hemorragia Intracraneal (ICH) conlleva una importante carga de morbilidad y mortalidad; sin embargo, existe escasa información en Latinoamérica.

Objetivo:

Analizar el pronóstico funcional y las tasas de mortalidad entre los participantes del Registro Latinoamericano de Enfermedad Vascular Cerebral (LASE).

Métodos:

Dieciocho centros de toda Latinoamérica recopilaron datos demográficos, factores de riesgo vascular, descripción clínica, pruebas auxiliares y resultados funcionales en la estancia hospitalaria de los pacientes incluidos entre enero de 2012 y enero de 2017. Todas estas variables se analizaron en función del resultado funcional al alta hospitalaria.

Resultados:

Se incluyeron 495 pacientes con ICH, que representan el 10.3% de todos los subtipos de enfermedad vascular cerebral en LASE. La mediana de estancia hospitalaria fue de 9 dias (rango intercuartil, 1-30); 285 (57.6%) fueron hombres (mediana de edad, 62 años) and 210 mujeres (mediana de edad, 65 años). Un mal resultado funcional (Escala modificada de Rankin, 3-6) fue observado en 214 (43.2%) pacientes, con un 62.5% de mujeres (p < 0.009). Se documento mortalidad en 12.5% de los pacientes con ICH. Las curvas de supervivencia de Kaplan-Meier presentaron diferencias en la mortalidad, con mayor frecuencia en pacientes > 80 años (HR 1.89, 95% IC 1.07-3.35, p = 0.028), con GCS < 8 (HR 0.19, 95% IC 0.11-0.33, p = < 0.001), irrupción ventricular (HR 1.88, 95% IC 1.09-3.24, p = 0.0282), y volumen del hematoma > 30 cc (HR 2.36, 95% IC 1.17-4.77, p = 0.016).

Conclusiones:

Nuestro estudio demuestra un mal pronóstico funcional en 43.2% de los pacientes con ICH, siendo los factores de riesgo de mayor mortalidad la edad mayor de 80 años, los valores más bajos de GCS y la irrupción ventricular en el LASE. Nuestro estudio colaborativo aporta información sustancial sobre los factores que influyen en la aparición, el pronóstico y los resultados de la ICH en Latinoamérica.

Palabras clave Hemorragia Intracraneal; Latinoamérica; Registro de Enfermedad Vascular Cerebral; Resultado de la enfermedad vascular cerebral

Introduction

Stroke is one of the leading causes of death and disability worldwide. In 2019, the global burden of stroke had 6.5 million deaths and 143 million disability-adjusted life-years (DALY)1,2. Intracerebral hemorrhage (ICH) represents approximately 20% of strokes and is its most severe and least treatable form.

The incidence of ICH is 3.41 million2,3 but can vary significantly based on geographic location, population demographics, among other epidemiologic characteristics. ICH accounts for 5 to 20% of cerebrovascular disease in high-income countries (HICs); however, in low-and middle-income countries (LMICs), the disease burden is higher for ICH. Although the reasons for the higher burden of disease derived from ICH compared to ischemic stroke are not entirely established in LMICs, several factors have been identified, such as high prevalence of poorly controlled hypertension and high sodium intake in local diets4. Hospital-based studies from Ecuador, Mexico, Chile and Argentina report a proportion of ICH between 23 and 40%5,6. There is also a high incidence of ICH in Asia5 and in black compared to white populations from HICs7.

Additionally, ICH produces the highest mortality (50%)8 and accounts for 42% of all the disability-adjusted years lost due to stroke6 Despite all the above data, there are few ICH data published from LMICs of the Latin American region, and the scarce data available has been mainly derived from single-center hospital registries, which present the inherent selection bias of this type of study9.

The LASE (Latin American Stroke Registry) initiative was instituted using robust data compilation and structured methodology to explore multiple stroke outcomes in a population-based sample from tertiary hospitals in Latin America. The present study analyzes the functional outcome, recurrence and death among LASE participants with ICH.

Material and methods

The LASE is a multicenter stroke registry from tertiary referral hospitals with ongoing stroke registries from Central and Andean Latin America, designed to improve knowledge of stroke In the region. Participating sites recruited patients from January 2012 to January 2017. The corresponding Institutional Ethics Committee approved all stroke datasets by international and local research regulations and waived the need for signed informed consent. Still, the patient or a family member verbally agreed to the record of anonymized data in the registry. LASE data comes from 18 centers located in seven Latin American countries. Ten centers from Mexico [Mexico City (5), Durango, Morelia, Madero and Guadalajara (2)], two from Colombia (Bogotá and Cali), two from Perú (both in Lima), and one center from Argentina (Buenos Aires), Costa Rica (San José), Paraguay (Asunción), and Ecuador (Quito). The complete methods of the LASE registry have been published elsewhere10.

Study’s definitions and criteria

Spontaneous ICH was defined as a blood collection within the brain parenchyma secondary to vascular rupture- that was neither traumatic nor aneurysmal in origin. The inclusion criterion for the present analysis was patients with ICH confirmed by imaging studies. We included cases without a demonstrated aneurysmal or traumatic cause11. The cause of ICH was attributed to hypertension in patients with a history of hypertension with regular o irregular treatment and ICH located in sites traditionally associated with hypertension11. Cerebral amyloid angiopathy is a cerebral deposition of amyloid-β, this etiology was attributed to cases with features such as lobar hemorrhage, lobar microhemorrhages and superficial siderosis12. Only patients aged 18 years and older were included. Cases diagnosed with subarachnoid hemorrhage and those with incomplete information were excluded. Information was collected from the original datasets of each center and compiled into a single database by two authors (FS and MAB). The data includes demographic characteristics such as age, sex, and place of residence. Registered vascular risk factors were hypertension, atrial fibrillation, ischemic cardiopathy, diabetes mellitus, and smoking (current or former). Clinical characteristics, such as the NIHSS and Glasgow Como Scale at admission, were also documented. All patients underwent at least one brain imaging study (CT or MRI) to confirm ICH diagnosis. Clinical outcome was systematically recorded at discharge, as measured by the modified Rankin scale (mRs). Follow-up was not included since most centers only register in-hospital data. A poor clinical outcome was defined as a mRs ranging from 3 to 6, while a good clinical outcome was characterized by a score of 0 to 2. Mortality in this period was analyzed regardless of whether death was considered or not related to ICH.

Statistical analysis

Continuous data is summarized by the mean and standard deviation (SD) or the median and interquartile range according to the results of normality tests (Kolmogorov-Smirnoff test). Categorical data is presented as counts and percentages.

Association analysis of continuous data (age, in-hospital length stay) was done with the Mann–Whitney U or Student t-test according to normality. The chi-squared test or Fisher’s exact test adjustment was employed for dichotomous data (including vascular risk factors, demographics, type of ICH, functional outcome, recurrence, and death).

Kaplan–Meier survival curves and the Log-Rank test were utilized to evaluate the absolute risk of death in ICH events during the acute in-hospital period. Significance was defined at p < 0.05. Hazard ratios (HRs) and 95% CIs were calculated.

All statistical analyses were calculated using the SPSS 29.0.1.0 software package (SPSS Statistics for Windows, IBM Corp., Armonk, NY).

Results

Demographics

We recruited data from 5336 patients, 508 of these patents were excluded because of the absence of complete information (medical records and neuroimaging). Only 4828 patients with a confirmed imaging diagnosis and complete inpatient clinical information were included in the analysis. Among these patients, 495 corresponded to intracranial hemorrhage, representing 10.3% of all collected stroke subtypes in LASE.

Of the 18 participating centers, three centers did not contribute patients to the database because their neurosurgery departments were responsible for the evaluation, treatment, and follow-up of ICH patients, and the corresponding clinical neurology departments had no access to the data. The median age of all patients was 64 years (interquartile range, 18-94). Among the patients, there were 285 (57.6%) males (median age, 62 years, interquartile range, 18-94) and 210 (42.4%) females (median age, 65 years, interquartile range, 18-93).

Vascular risk factors

The most common vascular risk factor was hypertension, identified in 339 patients (68.5%), followed by smoking (12.9 %) and diabetes (17.8 %). The predominant etiology was hypertensive in 75 % of cases, 5.9% had arteriovenous malformatios, 4% had no aneurysmal subarachnoid hemorrhage, 3.8% had cerebral amyloid angiopathy, 2.8% were related to drugs (anticoagulants/antiplatelet) and 7.7% were undetermined due to incomplete studies. Table 1 presents the general characteristics and risk factors based on functional prognosis upon hospital discharge.

Table 1 General characteristics, vascular risk factors, etiology and treatment according to functional prognosis at hospital discharge 

Variable Good clinical outcome mRs 0 - 2 (n = 281 [%]) Poor clinical outcome mRs 3 - 6 (n = 214 [%]) Total (n = 495) p value
Age, ya 73 (24-89) 67 (37-90) 68 (24-90) < 0.001*
Male 176 (62.6%) 109 (50.9%) 285 (57.6%) 0.009
Hospital stay, d 8 (1-34) 10.5 (SD 8.3) 9 (1-30) 0.280*
Risk factors
Hypertension 174 (61.9%) 165 (77.1%) 339 (68.5%) < 0.001
Diabetes mellitus 35 (12.5%) 53 (24.8 %) 88 (17.8%) < 0.001
Current smoking 41 (18.3%) 23 (11.2%) 64 (14.9%) 0.121
Coronary disease 8 (2.8%) 11 (5.1%) 19 (3.8%) 0.188
Hypercholesterolemia 34 (12.1%) 31 (14.5%) 65 (13.1%) 0.330
Atrial fibrillation 9 (3.2%) 13 (6.1%) 22 (4.4%) 0.125
Clinical and image
NIHSS at admission 10 (0-23) 15 (6-32) 12.5 pt (0-32) < 0.001*
Ventricular irruption 34 (12.1%) 53 (24.8%) 87 (17.6%) < 0.001
Hematoma volume > 30 cc 5 (1.8%) 26 (12.2%) 31 (6.3%) < 0.001+
Etiology
Hypertensive 189 (67.3%) 185 (86.4%) 374 (75 %) < 0.001
Amyloid angiopathy 7 (2.5 %) 12 (5.6%) 19 (3.8%) 0.074
Arteriovenous malformatios 13 (4.6%) 16 (7.5%) 29 (5.9%) 0.181
Drugs 4 (1.4%) 10 (4.7%) 14 (2.8%) 0.052+
No aneurysmal SAH 11 (3.9%) 10 (4.7%) 21 (4.2 %) 0.678
Not determined incomplete studies 16 (5.7 %) 22 (10.3%) 38 (7.7%) 0.058
Treatment
Conservative 273 (97.2%) 200 (93.5%) 473 (95.6%) 0.048
Medical Intensive 8 (2.8%) 14 (6.5%) 22 (4.4%) 0.048
Surgical 13 (4.6%) 17 (7.9%) 30 (6.1%) 0.125

aMedian (Interquartile Range).

*P value U-Mann-Whitney Wilcoxon. +Fisher’s Exact Test.

In-hospital outcome

Intracerebral hemorrhage presented an in-hospital bad functional outcome, with mRs of 3-6 observed in 214 patients (43.2%): 62.6% in women versus 50.9% in men (p = 0.009). The stroke recurrence during hospitalization was 5.9% (29 patients).

The mortality rate was 12.5% (62 patients). The risk of death was found non-significantly higher in men (6.9%) compared to women (5.7%) (p = 0.64). The optimal age cutoff for mortality was 80 years, with an area under curve (AUC) of 0.602. The Kaplan Meier survival curves, categorized by age, hematoma volume, ventricular irruption and Glasgow Coma Scale, are presented in Figure 1. However, there is a difference in mortality, with higher frequency, in patients aged over 80 years (HR 1.89, 95%CI 1.07-3.35, p = 0.028), with GCS below 8 (HR 0.19, 95%CI 0.11-0.33, p = < 0.001), ventricular irruption (HR 1.88, 95%CI 1.09-3.24, p = 0.0282), and hematoma volume exceeding 30 cc (HR 2.36, 95%CI 1.17-4.77, p = 0.016).

Figure 1 Kaplan-Meier curves: A: mortality according to age, B: mortality according to hematoma volume, C: mortality according to the occurrence of ventricular irruption and D: mortality according to Glasgow Coma Scale. 

Discussion

This analysis showed that ICH represents 10% of our registry. This finding is of great importance since it indicates an underreporting of ICH in the region. In some LASE sites, ICH represented less than 5% of stroke cases, which is lower than other reported ICH series. This could be associated with the fact that in some centers, patients with ICH are managed by the neurosurgery service. The management of acute stroke, especially ICH, in Latin America differs from other regions, and several countries do not have a national plan for stroke13. However, many of the ICH cases occur in low and middle-income countries, such as those included in LASE, mainly explained by lower levels of consciousness and poor control of hypertension. In this registry, nearly 60% of the ICH were hypertensive. Management of this critical risk factor could reduce the functional and socioeconomic impact of ICH.

Exploring the factors contributing to ICH within Hispanic populations, the National Institute of Neurology and Neurosurgery-Stroke Registry in Mexico14 highlighted the prevalence of hypertension (85.1%) among ICH patients Our study also identified a high prevalence of hypertension (68.5%) in ICH patients within LASE. Other risk factors revealed in our study included diabetes mellitus in 17.8% of the cases, which is higher compared to other reports where it is 9%15,16.

Our findings also mirrored previous reports, indicating a worse functional outcome among ICH patients. 43% of our cases had poor functional prognosis, with a mortality rate of 12.5%, mainly attributed to advanced age (> 80 years), greater bleeding severity (ventricular irruption and hematoma volume exceeding 30 cc) and GCS below 8. Midline shift, lobar and supratentorial bleeds as well as high presenting SBP and nonconsumption of leafy green vegetables, have also been described as predictors of mortality16.

In the RENAMEVASC (a Mexican stroke registry), a 30-day mortality rate of 30% was reported, with a bad functional outcome present in 31% of the participants17. Romano et al. observed comparable stroke severity between Mexican and Miami Hispanic populations (11.6 + 7.6 in Mexico, 11.3 + 8.4 in Miami, p = 0.84)18, notably, Hispanics in the United States exhibit a heightened risk of ICH compared to non-Hispanic whites (OR 2.6, CI 1.4-6.1)18.

Our study represents a significant collaborative effort in Latin America, encompassing over 4000 patients from 18 diverse hospitals across seven countries. However, it has multiple limitations. First, the study has the inherent bias of retrospective observational studies. Second, there is a sub-representation of ICH cases, which does not accurately represent this stroke subtype’s reality in the entire country. Additionally, the unevenness of the data regarding the distinct aspects of ICH management across the participant countries should be emphasized. Finally, it was impossible to register follow-up data from the participants, which does not add to our understanding of the mid and long-term outcomes of ICH. Despite these limitations, the LASE initiative is and will continue to be a valuable tool to improve stroke knowledge, providing accurate and systematically recorded data from Latin American patients with stroke. Additionally, our findings highlight the urgent need for more reliable data on ICH in Latin America and serve as a call to action to identify and control arterial hypertension early.

Conclusion

Our study demonstrates a poor functional prognosis in 43.2% of ICH patients, with the risk factors for higher mortality being age over 80 years, higher GCS values, and ventricular irruption. Our collaborative study contributes substantial insight into the factors influencing ICH occurrence, prognosis, and outcomes in Latin America. While sharing similarities with global stroke registries, it provides valuable region-specific information that could guide targeted interventions and healthcare strategies. Additionally, the complexities of ethnic and genetic influences on ICH risk are highlighted, as well as the importance of continuous monitoring and improvement of healthcare practices to enhance outcomes in this population.

Acknowledgments

Fabiola Serrano (CVU 543171) thanks the National Council for Science and Technology (CONACYT) and Doctoral Program in Medical Sciences (PMDCMOS), National Autonomous University of Mexico (UNAM). Thanks to the LASE co-investigators and Collaborators: Ana M. Valencia-Chavez, MD; María P. Rosa Calle-La, MD; Carlos Abanto-Argomedo, MD; Larry Benavides-Vasquez, MD; Ricardo Otiniano-Sinfuentes, MD (Neurology Department, Instituto Nacional de Ciencias Neurológicas, Lima, Peru). Ricardo Mernes, MD; Christian Otto, MD (Neurology Department, Facultad de Ciencias Medicas, Universidad Nacional de Asunción, Paraguay). Jaime Valderrama, MD (Neurology Department Fundacion Clínica Valle del Lili, Cali, Colombia). Carlos F. Martínez, MD; Jaime E. Rodrıguez, MD; Brenda V. Ropero, MD (Stroke Center, Neurology Department, Hospital Universitario Fundación Santa Fe de Bogota, Colombia). German Lopez-Valencia, MD (Neurology Department, Hospital Civil Fray Antonio Alcade, Guadalajara, Jalisco, Mexico). Carmen Arteaga, MD; Beatriz Mendez, MD; Cristina Ramos, MD (Stroke Department, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suarez, Mexico City, Mexico). Gabriel Torrealba, MD; Huberth Fernandez (Neurosciences Department Hospital Dr. Rafael Calderon Guardia (CCSS), San Jose, Costa Rica). Eugenia Morelos (Neurology Department, Hospital Regional del ISSSTE, Morelia, Mexico).

References

1. Krishnamurthi, R. V., Ikeda, T. &Feigin, V. L. Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage:A Systematic Analysis of the Global Burden of Disease Study 2017. Neuroepidemiology. 2020. 54, 171-179. [ Links ]

2. Feigin, V. L. et al. Global, regional, and national burden of stroke and its risk factors, 1990-2019:a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021. 20, 795-820. [ Links ]

3. Cai, X. &Rosand, J. The Evaluation and Management of Adult Intracerebral Hemorrhage. Semin Neurol (2015) 35, 638-645. [ Links ]

4. Estol, C. J., Bath, P. M. W., Gorelick, P. B., Cotton, D. &Martin, R. H. Differences in Ischemic and Hemorrhagic Recurrence Rates among Race-Ethnic Groups in the PRoFESS Secondary Stroke Prevention Trial. International Journal of Stroke. 2014. 9, 43-47. [ Links ]

5. Amin, H;Schindler, J. Intracranial Hemorrhage. Amin, H;Schindler, J. Vascular Neurology Board Review. Springer International Publishing, 2017. p128-134 [ Links ]

6. Casolla, B., Tortuyaux, R. &Cordonnier, C. Management of spontaneous intracerebral haemorrhages. Presse Med. 2016. 45, e419-e428. [ Links ]

7. Faigle, R., Marsh, E. B., Llinas, R. H., Urrutia, V. C. &Gottesman, R. F. Race-Specific Predictors of Mortality in Intracerebral Hemorrhage:Differential Impacts of Intraventricular Hemorrhage and Age Among Blacks and Whites. J Am Heart Assoc. 2016. 5, e003540. [ Links ]

8. De Ridder, I. et al. No sex differences in long-term functional outcome after intracerebral hemorrhage. International Journal of Stroke. 2017.12, 416-420. [ Links ]

9. Krumholz, H. M. Registries and Selection Bias. Circ Cardiovasc Qual Outcomes. 2009. 2, 517-518. [ Links ]

10. Arauz, A. et al. Sex Differences Among Participants in the Latin American Stroke Registry. J Am Heart Assoc. 2020. 9:e013903. [ Links ]

11. Greenberg, S. M. et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage:A Guideline From the American Heart Association/American Stroke Association. Stroke. 2022. 53, E282-E361. [ Links ]

12. Biessels, G. J. Cerebral Amyloid Angiopathy. Stroke. 2020. 51, 3487-3488. [ Links ]

13. Ouriques Martins, S. C. et al. Priorities to reduce the burden of stroke in Latin American countries. Lancet Neurol. 2029. 18, 674-683. [ Links ]

14. Arauz, A. et al. Mexican-National Institute of Neurology and Neurosurgery-Stroke Registry:Results of a 25-Year Hospital-Based Study. Front Neurol. 2018. 9. Article 207. [ Links ]

15. Sun, S. et al. Prognostic Value of Admission Blood Glucose in Diabetic and Non-diabetic Patients with Intracerebral Hemorrhage. Sci Rep. 2016. 6, 1-7 [ Links ]

16. Sarfo, F. S. et al. Unraveling the risk factors for spontaneous intracerebral hemorrhage among West Africans. Neurology. 2020. 94, e998-e1012. [ Links ]

17. Ruiz Sandoval, J. L. et al. Hemorragia intracerebral espontánea en México:resultados del Registro Hospitalario Multicéntrico Nacional en Enfermedad Vascular Cerebral (RENAMEVASC). 2011. Rev Neurol 53, 705-712. [ Links ]

18. Romano, J. G. et al. Disparities in Stroke Type and Vascular Risk Factors Between 2 Hispanic Populations in Miami and Mexico City. Journal of Stroke and Cerebrovascular Diseases. 2013. 22, 828-833. [ Links ]

FundingThe authors declare that this work was carried out with the authors’ own resources.

Ethical disclosures

Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data. The authors declare that no patient data appear in this article.

Right to privacy and informed consent. The authors declare that no patient data appear in this article.

Use of artificial intelligence for generating text. The authors declare that they have not used any type of generative artificial intelligence for the writing of this manuscript, nor for the creation of images, graphics, tables, or their corresponding captions.

Received: August 17, 2023; Accepted: August 21, 2023

* Correspondence: Antonio Arauz E-mail: antonio.arauz@prodigy.net.mx

Conflicts of interest

The authors declare that they have no conflicts of interest.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open ccess article under the CC BY-NC-ND license